| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 8, 2006
From the Department of Radiology, Mayo Clinic, Rochester, MN. * To whom correspondence should be addressed. E-mail: Kallmes.david{at}mayo.edu.
Background and Purpose--We report a preclinical study of a new endoluminal device for aneurysm occlusion to test the hypothesis that the device, even without use of intrasaccular coil placement, could occlude saccular aneurysms without causing substantial parent artery compromise or compromise of adjacent, small branch arteries. Methods--The Pipeline Neuroendovascular Device (Pipeline NED; Chestnut Medical Technologies, Inc) is a braided, tubular, bimetallic endoluminal implant aimed at occlusion of saccular aneurysms through flow disruption along the aneurysm neck. The device was implanted across the necks of 17 elastase-induced aneurysms in the New Zealand white rabbit model and followed for 1 month (n=6), 3 months (n=5), and 6 months (n=6). In each subject, a second device was implanted in the abdominal aorta to cover the origins of lumbar arteries. Aneurysm occlusion rates by angiography (grade 1, complete occlusion; grade 2, near-complete occlusion; and grade 3, incomplete occlusion) were documented. Percent area stenosis of the parent arteries was calculated. Presence of distal emboli in the downstream vessels in the parent artery and branch artery stenosis or occlusion was noted. Results--Grades 1, 2, and 3 occlusion rates were noted in 9 (53%), 6 (35%), and 2 (12%) of 17 aneurysms, respectively, indicating an 88% rate of complete or near complete occlusion. No cases of branch artery occlusion or distal emboli in the downstream vessels of the parent artery, specifically the subclavian artery, were seen. Parent artery compromise from neointimal hyperplasia was minimal in most cases. Conclusions--The Pipeline NED is a trackable, bio- and hemocompatible device able to occlude saccular aneurysms with preservation of the parent artery and small, adjacent branch vessels.
Revised on January 26, 2007
Accepted on February 20, 2007
A New Endoluminal, Flow-Disrupting Device for Treatment of Saccular Aneurysms
David F. Kallmes MD*;
This article has been cited by other articles:
![]() |
D Fiorella, F Albuquerque, F Gonzalez, C G McDougall, and P K Nelson Reconstruction of the right anterior circulation with the Pipeline embolization device to achieve curative treatment of a large, progressively symptomatic, enlarging carotid-ophthalmic segment aneurysm arising from a dolichoectatic carotid and middle cerebral artery JNIS, September 16, 2009; (2009) jnis.2009.000554v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.I. Park, B.M. Kim, D.I. Kim, Y.S. Shin, S.H. Suh, E.C. Chung, S.Y. Kim, S.H. Kim, and Y.S. Won Clinical and Angiographic Follow-Up of Stent-Only Therapy for Acute Intracranial Vertebrobasilar Dissecting Aneurysms AJNR Am. J. Neuroradiol., August 1, 2009; 30(7): 1351 - 1356. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Fiorella, P Lylyk, I Szikora, M E Kelly, F C Albuquerque, C G McDougall, and P K Nelson Curative cerebrovascular reconstruction with the Pipeline embolization device: the emergence of definitive endovascular therapy for intracranial aneurysms JNIS, July 1, 2009; 1(1): 56 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.F. Kallmes, Y.H. Ding, D. Dai, R. Kadirvel, D.A. Lewis, and H.J. Cloft A Second-Generation, Endoluminal, Flow-Disrupting Device for Treatment of Saccular Aneurysms AJNR Am. J. Neuroradiol., June 1, 2009; 30(6): 1153 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Ionita, A. M. Paciorek, A. Dohatcu, K. R. Hoffmann, D. R. Bednarek, J. Kolega, E. I. Levy, L. N. Hopkins, S. Rudin, and J. D. Mocco The Asymmetric Vascular Stent: Efficacy in a Rabbit Aneurysm Model Stroke, March 1, 2009; 40(3): 959 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sadasivan, L. Cesar, J. Seong, A. Rakian, Q. Hao, F. O. Tio, A. K. Wakhloo, and B. B. Lieber An Original Flow Diversion Device for the Treatment of Intracranial Aneurysms: Evaluation in the Rabbit Elastase-Induced Model Stroke, March 1, 2009; 40(3): 952 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Wakhloo, J. Mandell, M. J. Gounis, C. Brooks, I. Linfante, J. Winer, and J. P. Weaver Stent-Assisted Reconstructive Endovascular Repair of Cranial Fusiform Atherosclerotic and Dissecting Aneurysms: Long-Term Clinical and Angiographic Follow-Up Stroke, December 1, 2008; 39(12): 3288 - 3296. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kadirvel, Y.-H. Ding, D. Dai, D.A. Lewis, S. Raghavakaimal, H.J. Cloft, and D.F. Kallmes Gene Expression Profiling of Experimental Saccular Aneurysms Using Deoxyribonucleic Acid Microarrays AJNR Am. J. Neuroradiol., September 1, 2008; 29(8): 1566 - 1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Ionita, A. M. Paciorek, K. R. Hoffmann, D. R. Bednarek, J. Yamamoto, J. Kolega, E. I. Levy, L. N. Hopkins, S. Rudin, and J Mocco Asymmetric Vascular Stent: Feasibility Study of a New Low-Porosity Patch-Containing Stent Stroke, July 1, 2008; 39(7): 2105 - 2113. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Pelz, E. I. Levy, and L. N. Hopkins Advances in Interventional Neuroradiology 2007 Stroke, February 1, 2008; 39(2): 268 - 272. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |